Amble vs AquaVita NextGen
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
AquaVita NextGen
Best for patients in AZ/CA/FL/TX/NV seeking medspa-backed GLP-1 with a named medical directorSide-by-Side Comparison
| Feature | Amble | AquaVita NextGen |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.9/10 |
| Starting Price | $179/mo | — |
| Editorial Rating | ✓3.7 ★ /5 | 3.5 ★ /5 |
| Features | 3 features | 3 features |
| States Available | ✓50 | 5 |
| Compounded | ✓ Yes | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
AquaVita NextGen
Pros
- ✓Physical address in Lake Forest CA
- ✓Named medical director (Dr. Steve Groke)
- ✓Both semaglutide and tirzepatide including ODT tablets
- ✓Compounding disclaimer present on site
Cons
- ✗Only 5 states (AZ, CA, FL, TX, NV)
- ✗Pricing not publicly displayed ($00.0 placeholders)
- ✗No LegitScript or PCAB accreditation
- ✗Primarily a local medspa expanding into telehealth
Our Verdict
Amble edges out AquaVita NextGen with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. AquaVita NextGen remains a solid alternative, especially if you're looking for patients in AZ/CA/FL/TX/NV seeking medspa-backed GLP-1 with a named medical director.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.